2025-10-03T15:24:19-05:00 2024-12-31 420714325 RSM US LLP 919 EAST MAIN STREET SUITE 1800 RICHMOND VA 23219 990 2024-01-01 460917764 NATIONAL ASSOCIATION OF SPECIALTY PHARMACY INC NATI 7038420122 300 NEW JERSEY AVENUE NW 900 WASHINGTON DC 20001 ERIK HALSTROM BOARD SECRETARY/TREASURER 7038420122 2025-10-01 1 1 MEREDITH BELL P01696827 8042822121 2025-09-25 2024 2025-03-06 01:10:19Z SHEILA ARQUETTE 300 NEW JERSEY AVENUE NW 900 WASHINGTON DC 20001 6723595 0 X WWW.NASPNET.ORG X 2012 FL TO PROVIDE EDUCATIONAL PROGRAMS, CERTIFICATION CURRICULUM AND PROFESSIONAL NETWORKING FORUMS FOR HEALTHCARE PROFESSIONALS TO PROMOTE THE SAFE AND APPROPRIATE USE OF SPECIALTY MEDICATIONS AND IMPROVE CLINICAL AND ECONOMIC OUTCOMES. 33 33 9 600 0 0 2500 40151 4606791 5565395 90891 114788 49215 4720 4749397 5725054 5000 12500 0 0 1188123 1166177 0 0 0 3241375 3785945 4434498 4964622 314899 760432 3299653 3623774 1521438 1081693 1778215 2542081 X THE MISSION OF THE NATIONAL ASSOCIATION OF SPECIALTY PHARMACY (NASP) IS TO ELEVATE THE PRACTICE OF SPECIALTY PHARMACY BY DEVELOPING, DELIVERING, AND PROMOTING CONTINUING PROFESSIONAL EDUCATION AND SPECIALTY CERTIFICATION WHILE ADVOCATING FOR PUBLIC POLICIES THAT ENSURE PATIENTS HAVE APPROPRIATE ACCESS TO SPECIALTY MEDICATIONS IN TANDEM WITH CRITICAL SERVICES. 0 0 ANNUAL MEETING - EACH YEAR, THE ORGANIZATION'S MEMBERS, INDUSTRY THOUGHT LEADERS, AND HEALTHCARE VETERANS FROM AROUND THE COUNTRY COME TOGETHER TO SHAPE THE FUTURE OF SPECIALTY PHARMACY AND THE PATIENT JOURNEY. THE ANNUAL MEETING PROVIDES INTERACTIVE LEARNING, SHARING BEST PRACTICES, EXPLORING POTENTIAL PARTNERSHIPS AND SYNERGIES, AND FOSTERING CONNECTIVITY IN A PERSONALIZED, ENERGIZED, AND INTERACTIVE SETTING. ADVOCACY- THE ORGANIZATION IS THE ONLY NATIONAL ASSOCIATION REPRESENTING ALL SPECIALTY PHARMACY INDUSTRY STAKEHOLDERS, AMPLIFYING MEMBERS' COLLECTIVE VOICES THROUGH A MULTI-PRONGED, COORDINATED EFFORT DESIGNED TO EDUCATE, ADVOCATE, AND AFFECT POSITIVE CHANGE WITH CONGRESSIONAL AND ADMINISTRATIVE POLICY MAKERS, ELECTED OFFICIALS, KEY CONGRESSIONAL STAFFERS, ALIGNED PHARMACY, AND HEALTHCARE AND PATIENT ADVOCACY ASSOCIATIONS. EDUCATION AND OTHER - THE ORGANIZATION OFFERS EDUCATION AND OTHER PROGRAMS DESIGNED TO IMPROVE THE SKILLS OF PHARMACY STUDENTS AND MEMBERS IN THE PROCESS OF OBTAINING OR RENEWING THEIR CERTIFICATION. CERTIFICATION - THE CERTIFIED SPECIALTY PHARMACIST (CSP) CREDENTIAL HAS BEEN DEVELOPED TO RECOGNIZE INDIVIDUALS WHO HAVE DEMONSTRATED INTERMEDIATE KNOWLEDGE AND SKILL TO PROVIDE COMPETENT SPECIALTY PHARMACY SERVICES. THE CSP CREDENTIAL IS A KEY INDICATOR TO EMPLOYERS, MANUFACTURERS, PATIENTS, PAYERS, ADDITIONAL HEALTHCARE PROVIDERS, AND THE PUBLIC AT LARGE THAT A PHARMACIST HAS PROFICIENCY IN SPECIALTY PHARMACEUTICALS. 0 1 1 1 0 0 0 0 0 1 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0 1 0 0 0 0 0 0 1 0 0 1 16 0 1 9 1 0 0 0 0 1 1 0 0 0 X 33 33 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 0 X X SHEILA ARQUETTE 7038420122 300 NEW JERSEY AVENUE NW 900 WASHINGTON DC 20001 KYLE SKIERMONT IMMEDIATE PAST CHAIR 2.00 X X 0 0 0 SCOTT GUISINGER CHAIR 4.00 X X 0 0 0 ERIK HALSTROM SECRETARY/TREASURER 3.00 X X 0 0 0 CARMINE DENARDO DIRECTOR 4.00 X 0 0 0 NATALIE BEDFORD DIRECTOR 0.25 X 0 0 0 NICK CALLA DIRECTOR 0.25 X 0 0 0 KELLI HEATHMAN DIRECTOR 0.25 X 0 0 0 MICHAEL NAMETH DIRECTOR 0.25 X 0 0 0 REBECCA SHANAHAN DIRECTOR 0.25 X 0 0 0 ALEATA POSTELL DIRECTOR 0.20 X 0 0 0 ALEXANDRA BROADUS DIRECTOR (THRU 8/28/24) 0.20 X 0 0 0 ANGIE OSTER DIRECTOR 0.20 X 0 0 0 BENITO FERNANDEZ DIRECTOR 0.20 X 0 0 0 BINNY JOHN DIRECTOR 0.20 X 0 0 0 CHANDRA WAHRGREN DIRECTOR 0.20 X 0 0 0 GREG ISAAK DIRECTOR 0.20 X 0 0 0 GUILLERMO SOLLBERGER DIRECTOR (THRU 9/30/24) 0.20 X 0 0 0 JENNIFER NOONAN DIRECTOR 0.20 X 0 0 0 JOE MORSE DIRECTOR 0.20 X 0 0 0 JOHN COLAIZZI DIRECTOR (AS OF 10/1/24) 0.20 X 0 0 0 JOHN ROBICSEK DIRECTOR 0.20 X 0 0 0 KAREN SILVERBLATT DIRECTOR 0.20 X 0 0 0 KEITH COOK DIRECTOR 0.20 X 0 0 0 KRISTIN WILLIAMS DIRECTOR 0.20 X 0 0 0 LORI GREBE DIRECTOR (AS OF 10/1/24) 0.20 X 0 0 0 LUIS RODRIGUEZ DIRECTOR 0.20 X 0 0 0 MICAILA RUIZ DIRECTOR 0.20 X 0 0 0 MICHAEL BALDZICKI DIRECTOR 0.20 X 0 0 0 MICHAEL MCLENDON DIRECTOR (AS OF 10/1/24) 0.20 X 0 0 0 NANCY CROWELL DIRECTOR 0.20 X 0 0 0 PARMJIT AGARWAL DIRECTOR 0.20 X 0 0 0 REED KALNA DIRECTOR (THRU 9/30/24) 0.20 X 0 0 0 ROBERT NACE DIRECTOR 0.20 X 0 0 0 SHARON FAUST DIRECTOR (AS OF 10/1/24) 0.20 X 0 0 0 THOMAS COHN DIRECTOR 0.20 X 0 0 0 TIMOTHY WARD DIRECTOR 0.20 X 0 0 0 SHEILA ARQUETTE PRESIDENT & CEO 40.00 X 315489 0 17836 REBEKAH ANGUIANO DIRECTOR OF EDUCATION 40.00 X 171026 0 40490 ARIANNA ARQUETTE MEMBRSHP & BUS DEVLPMNT SPECIALIST 40.00 X 103303 0 13295 589818 0 71621 3 0 1 0 MEETING MANAGEMENT ASSOCIATES INC 16 WEST STONE STREET SHERBURNE NY 13460 MEETING & EXPO MANAGEMENT 1409260 POWERS PYLES SUTTER & VERVILLE PC 1501 M STREET NW SUITE 700 WASHINGTON DC 200051700 GOVERNMENT RELATIONS SUPPORT 469214 FREEMAN PO BOX 734596 DALLAS TX 75373 EXHIBIT HALL MANAGEMENT, SHOW SIGNAGE, A 171783 ACME NASHVILLE LLC 641 FOGG STREET NASHVILLE TN 37203 EVENT CATERING & VENUE SERVICES 113696 RSM US LLP 5155 PAYSPEHERE CIRCLE CHICAGO IL 606740051 ACCOUNTING SERVICES 101524 5 35151 5000 40151 ANNUAL MEETING 611430 3017074 3017074 MEMBERSHIP 900099 2045065 2045065 EDUCATION 611710 503256 503256 5565395 103329 103329 3214 3214 1010000 998541 11459 11459 11459 MISC. INCOME 900099 1506 1506 1506 5725054 5565395 0 119508 X 12500 544841 116598 397969 12562 22119 72088 87606 134645 46725 1943754 79537 30078 64502 233437 61777 782262 6800 27648 ACCREDITATION FEES 134625 PAYROLL FEES 81188 LICENSE FEES 53197 DUES & SUBSCRIPTIONS 18164 4964622 2750999 2042475 499560 1529912 4262 548 31799 44606 117600 111367 13033 6233 3299653 3623774 648478 237791 872960 843902 1521438 1081693 X 1778215 2542081 1778215 2542081 3299653 3623774 760432 3434 0 X X 0 1 X 1 0 RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 8733 0 0 1 2045066 46725 1308881 1355606 204507 1151099 PART I-A, LINE 1: NASP PAID $8,733 FOR ADMINISTRATIVE EXPENSES FOR NATIONAL ASSOCIATION OF SPECIALTY PHARMACY PAC. 117600 111367 6233 6233 5728488 3434 3434 5725054 0 5725054 4964622 0 4964622 0 4964622 1 SCHOLARSHIP 5 12500 PART I, LINE 2: NASP MAKES THE CHECKS PAYABLE TO THE COLLEGE/UNIVERSITY AND RELEASES THE FUNDS TO THE FINANCE OFFICE OF THE SCHOOL AND NOT THE STUDENT DIRECTLY WITH THE CAVEAT THAT FUNDS CAN ONLY BE USED FOR TUITION, FEES, AND BOOKS. THE SCHOOL ACCEPTING THE MONEY WILL ONLY PROCESS IF THE STUDENT IS AN ACTIVE STUDENT. NASP DOES NOT HAVE AN AGREEMENT. STUDENTS ARE REQUIRED TO PROVIDE THEIR TRANSCRIPTS AND STATE ON THE APPLICATION THEY ARE ENROLLED TO BE CONSIDERED. X 0 0 0 SHEILA ARQUETTE PRESIDENT & CEO 215565 0 99924 0 0 0 12707 0 5129 0 333325 0 0 0 REBEKAH ANGUIANO DIRECTOR OF EDUCATION 143276 0 22750 0 5000 0 7155 0 33335 0 211516 0 0 0 ARIANNA ARQUETTE FAMILY MEMBER OF PRESIDENT & CEO 114079 EMPLOYMENT 0 FORM 990, PART VI, SECTION B, LINE 11B A DRAFT OF THE FORM 990 IS REVIEWED AND DISCUSSED BY THE PRESIDENT/CEO AND THE SECRETARY/TREASURER PRIOR TO FILING WITH THE IRS. FORM 990, PART VI, SECTION B, LINE 12C ALL NASP STAFF, COMMITTEE MEMBERS, AND BOARD MEMBERS ARE SUBJECT TO THE ORGANIZATION'S CONFLICT OF INTEREST POLICY. EACH INDIVIDUAL IS PROVIDED WITH A COPY OF THE CURRENT POLICY AND IS REQUIRED TO ATTEST THAT THEY HAVE READ, UNDERSTAND, AND AGREE TO COMPLY WITH ITS PROVISIONS. WHEN A POTENTIAL CONFLICT OF INTEREST ARISES, THE INDIVIDUAL MUST PROMPTLY DISCLOSE THE MATTER TO THE BOARD CHAIR AND THE PRESIDENT/CEO. THESE OFFICERS JOINTLY REVIEW THE DISCLOSURE TO DETERMINE WHETHER A CONFLICT EXISTS. IF NEEDED, THE MATTER IS REFERRED TO LEGAL COUNSEL FOR FURTHER EVALUATION. INDIVIDUALS DETERMINED TO HAVE A CONFLICT ARE EXCLUDED FROM ANY RELATED DISCUSSIONS, DELIBERATIONS, AND DECISION-MAKING PROCESSES TO ENSURE IMPARTIALITY AND UPHOLD THE INTEGRITY OF THE ORGANIZATION'S GOVERNANCE. FORM 990, PART VI, SECTION B, LINE 15 A COMPENSATION COMMITTEE COMPOSED OF THE CURRENT BOARD CHAIR, TWO PAST BOARD CHAIRS, AND THE BOARD SECRETARY/TREASURER MEETS TO DISCUSS THE PRESIDENT/CEO'S PERFORMANCE AND CURRENT ECONOMIC TRENDS. BASED ON THIS REVIEW, THE COMMITTEE DETERMINES ANY MERIT INCREASE AND BONUS CALCULATION, TAKING INTO ACCOUNT THE ACHIEVEMENT OF INDIVIDUAL AND ORGANIZATIONAL GOALS. AN EXECUTIVE COMPENSATION EVALUATION WAS CONDUCTED IN JULY 2024. THE PRESIDENT/CEO WORKS WITH THE BOARD CHAIR TO ASSESS THE KEY EMPLOYEE'S PERFORMANCE AGAINST PERSONAL AND ORGANIZATIONAL GOALS AND RECOMMENDS ANY MERIT INCREASE OR BONUS. THE PRESIDENT/CEO CONSULTS WITH THE APPROPRIATE HR AND COMPENSATION RESOURCES TO OBTAIN CURRENT SALARY BENCHMARKS BASED ON JOB TITLE, RESPONSIBILITIES, AND GEOGRAPHIC LOCATION. FORM 990, PART VI, SECTION C, LINE 19 THESE DOCUMENTS ARE MADE AVAILABLE TO THE GENERAL PUBLIC UPON REQUEST FOR THE SAME PERIOD OF DISCLOSURE AS SET FORTH IN SECTION 6104(D). FORM 990, PART IX, LINE 11G CONSULTING 1,476,500. PUBLIC POLICY CONSULTING 467,254. FORM 990, PART XII, LINE 2C THE AUDIT COMMITTEE OVERSEES THE AUDIT AND SELECTION OF THE AUDIT FIRM. THE PROCESS HAS NOT CHANGED FROM THE PRIOR YEAR. NATIONAL ASSOCIATION OF SPECIALTY PHARMACY PAC 300 NEW JERSEY AVENUE NW SUITE 900 WASHINGTON DC 20001 831104316 POLITICAL ACTION COMMITTEE DC 527 NATIONAL ASSN OF SPECIALTY PHARMACY INC 1 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 0 0 0